Algo version: 0.98b
Lotus Pharmaceutical Co is listed at the TAI Exchange
Lotus Pharmaceutical Co [1795.TW]
TAI Sector: Healthcare Industry:Drug Manufacturers Specialty Generic

Is Lotus Pharmaceutical Co stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Lotus Pharmaceutical Co pays dividends. Last time was Friday 30th of August 2024 where the investors holding the stock on Monday 5th of August 2024 were paid TWD4.64745 per share. Over the last 8 times between 2008 and 2024, Lotus Pharmaceutical Co has paid TWD11.661737 with an average of TWD1.46 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Lotus Pharmaceutical Co 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was TWD110.00, you would have made a profit of TWD175.50 per share or 159.55%

Yes, the average daily trading liquidity for Lotus Pharmaceutical Co is TWD1.89 million. You should therefore be able to get in and out of your positions relatively fast.

Lotus Pharmaceutical Co has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.38, the company's ability to pay off the debt is normal. Lotus Pharmaceutical Co has a very good net profit margin of 24.63% and should have very high tolerances against inflation.

We have calculated the inflation risk for Lotus Pharmaceutical Co to be low [0.3 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.